High CCL2 Levels Detected in CSF of Patients with Pediatric Pseudotumor Cerebri Syndrome

Jacob Genizi*, Lotan Berger, Muhammad Mahajnah, Yulia Shlonsky, Orit Golan-Shany, Azriel Romem, Ayelet Halevy, Keren Nathan, Rajech Sharkia, Abdelnaser Zalan, Aharon Kessel, Rony Cohen

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Pseudotumor cerebri (PTC) is a disorder characterized by increased intracranial pressure in the absence of a structural lesion or other identifiable cause. Cytokines, which are involved in the regulation of immune responses and inflammation, have been implicated in the pathogenesis of PTC. In a prospective, cross-sectional study at three centers in Israel, we analyzed cerebrospinal fluid (CSF) samples from 60 children aged 0.5–18 years, including 43 children with a definitive diagnosis of PTC and a control group of 17 children. Levels of IL-4, IL-10, IL-17, CCL2, CCL7, CCL8, CCL13, BDNF, and IFN-γ were measured using ELISA kits. Levels of CCL2 were significantly higher in the PTC group compared to the control group (p < 0.05), with no other significant differences in the measured cytokines between the two groups. The groups did not differ significantly in clinical presentation, imaging, treatment, or ophthalmic findings. Our findings provide preliminary evidence that CCL2 may be involved in the pathogenesis of PTC and may serve a potential target for therapy in PTC.

Original languageEnglish
Article number1122
JournalChildren
Volume10
Issue number7
DOIs
StatePublished - Jul 2023

Funding

FundersFunder number
Israeli Pediatric Association
Triangle Research and Development Center

    Keywords

    • chemokines
    • cytokines
    • etiology
    • pediatrics
    • pseudotumor cerebri

    Fingerprint

    Dive into the research topics of 'High CCL2 Levels Detected in CSF of Patients with Pediatric Pseudotumor Cerebri Syndrome'. Together they form a unique fingerprint.

    Cite this